Your Trusted Restore Wellness Clinic Waco, Texas
FDA-approved Tirzepatide (Mounjaro / Zepbound) targets two metabolic hormones simultaneously delivering weight loss results that single agonist medications simply cannot match. Available at Restore Wellness Clinic in Waco, Texas.
Avg. Body Weight Reduction
Patients Achieved ≥5% Weight Loss
Hormone Pathways Targeted
SURMOUNT-1 Trial Duration
The Science
Tirzepatide is a once-weekly injectable medication developed by Eli Lilly and approved by the FDA for chronic weight management. It belongs to a new class of medications called dual GIP and GLP-1 receptor agonists meaning it activates two separate metabolic hormone pathways simultaneously.
You may know it by its brand names Mounjaro® (originally approved for type 2 diabetes) or Zepbound® (specifically approved for weight management). At Restore Wellness Clinic, we prescribe Tirzepatide as part of a comprehensive, physician supervised weight loss program tailored to each patient.
Enhances insulin secretion and improves how fat cells respond to insulin, accelerating fat breakdown.
Slows gastric emptying, signals the brain to reduce appetite, and improves blood sugar regulation.
The two pathways working together produce weight loss results significantly greater than either mechanism alone.
What sets Tirzepatide apart from all previous weight loss medications — including Semaglutide — is its dual-action mechanism. It is the only FDA-approved weight loss medication that targets both the GIP and GLP-1 hormone receptors:
First Target
Glucose-dependent insulinotropic polypeptide enhances fat metabolism, insulin sensitivity and energy storage regulation.
Second Target
Glucagon-like peptide-1 suppresses appetite, slows digestion, reduces food intake, and lowers blood sugar.
Clinical Evidence
Tirzepatide’s weight loss data is among the most impressive ever published in obesity medicine from a landmark Phase 3 clinical trial program involving thousands of patients.
Average body weight reduction at the highest dose (15mg) SURMOUNT-1
Of patients lost at least 5% of body weight
Of patients lost at least 20% of body weight
Patients enrolled in SURMOUNT-1 trial — robust dataset
The SURMOUNT-1 trial was a 72-week, randomized, double-blind, placebo-controlled Phase 3 study evaluating Tirzepatide in adults with obesity or overweight with at least one weight-related condition. Participants received once-weekly Tirzepatide at doses of 5mg, 10mg, or 15mg alongside lifestyle intervention. All three doses demonstrated statistically significant and clinically meaningful weight reduction vs. placebo — with the 15mg dose showing an average of 22.5% body weight reduction. *Individual results vary. Results shown reflect published clinical trial averages with lifestyle intervention.
Tirzepatide is FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity. Always consult a qualified provider before starting any medication.
Your Program
A clear, supported 4-step process from first consultation to measurable results with your provider guiding every step.
Your provider reviews your health history, current medications, and goals to determine if Tirzepatide is appropriate. Lab work may be ordered at this stage to establish baselines
A customized dosing schedule is created for you — starting at 2.5mg and titrating up over weeks based on your tolerance and progress. No cookie-cutter prescriptions.
You receive your medication with clear self-injection instructions, side effect guidance, and direct access to our team. Most patients notice appetite changes within the first 1–2 weeks.
Regular check-ins let your provider track your weight loss, manage any side effects, and adjust your dose as you progress through the titration schedule for maximum results.
Dosing Schedule
A realistic look at what your first months on a GLP-1 program typically look like so you know exactly what you’re signing up for.
The lowest dose allows your body to adjust gradually, minimizing side effects. Appetite suppression begins here.
Most patients begin noticing meaningful weight loss. Provider reviews response before next step.
Appetite suppression becomes consistent. Weight loss accelerates.
Patients often see the most significant progress at this stage.
The highest dose. Provider determines optimal maintenance level.
Tirzepatide is not a “set it and forget it” prescription. Our provider monitors your progress through regular check-ins and adjusts your dosing schedule based on how your body is responding always prioritizing safety and results.
You will never be escalated to a higher dose without your provider’s review and approval. If you’re achieving excellent results at a lower dose, there’s no need to go higher.
Self-administered injection into the abdomen, thigh, or upper arm. Easy to learn and fits into any weekly routine.
Tirzepatide must be refrigerated. Our team provides complete storage, handling, and administration instructions at your first appointment.
Questions between check-ins? Our clinic team is available to assist you are never navigating this alone.
Is This Right For You?
Our medically supervised programs are designed for individuals looking for safe, effective, and personalized weight management solutions.
Tirzepatide is FDA-approved for adults with a BMI of 30 or higher seeking clinically supervised weight management.
If you have high blood pressure, type 2 diabetes, sleep apnea, or high cholesterol alongside overweight, you may be an ideal candidate.
If diets, exercise programs, or even other medications haven’t produced lasting results, Tirzepatide’s dual-action mechanism offers a significantly stronger approach.
Tirzepatide is administered via a small, thin auto-injector pen once weekly. Our team provides full training and most patients adapt quickly.
Tirzepatide works best when paired with your provider’s lifestyle and nutrition guidance. Patients who follow their program consistently achieve the best outcomes.
Tirzepatide is not appropriate for everyone. Your provider will screen for contraindications during your consultation. Do not use Tirzepatide if you have:
The only way to know for sure is to speak with our provider. Consultations are straightforward and designed to give you honest, personalized guidance.
Beyond the Scale
Tirzepatide’s benefits extend well beyond weight loss its dual-action mechanism creates a cascade of positive metabolic effects throughout the body.
Clinical trials demonstrate average reductions of 20–22% of total body weight far exceeding what dieting alone or previous medications could achieve. For a 200lb person, that’s 40–44lbs of average loss.
Tirzepatide acts on hunger centers in the brain, reducing appetite and food cravings at the neurological level. Patients consistently report that food no longer dominates their thoughts.
Tirzepatide significantly improves insulin sensitivity and glucose regulation making it particularly beneficial for patients with pre-diabetes, insulin resistance, or type 2 diabetes.
Weight loss of 10–20% is associated with meaningful reductions in blood pressure, triglycerides, and cardiovascular risk. Ongoing trials are evaluating Tirzepatide’s direct cardiovascular protective effects.
Weight loss of 10–20% is associated with meaningful reductions in blood pressure, triglycerides, and cardiovascular risk. Ongoing trials are evaluating Tirzepatide’s direct cardiovascular protective effects.
As weight decreases, patients typically experience improved energy, reduced joint pain, better sleep quality, and significantly improved physical capability and stamina.
Unlike some weight loss approaches, GLP-1/GIP medications primarily drive fat loss while preserving lean muscle mass — especially when combined with adequate protein intake and exercise guidance from your provider.
Medication Comparison
We are not a one-size-fits-all clinic. Every patient receives individualized care, evidence based treatment and genuine provider support from day one to long-term success.
The critical difference between Tirzepatide and Semaglutide is mechanism depth. Semaglutide activates the GLP-1 receptor a powerful single pathway that suppresses appetite and improves blood sugar. Tirzepatide activates both GLP-1 and GIP receptors simultaneously.
The addition of GIP receptor activation enhances the body’s fat metabolism at a cellular level, improves insulin sensitivity further, and appears to amplify the appetite-suppressing effects of GLP-1. The clinical result is substantially greater weight loss clinical trials show approximately 7–8 percentage points more body weight reduction with Tirzepatide vs. Semaglutide.
For patients who want the most powerful FDA-approved tool available, Tirzepatide is the clear frontrunner. For patients who prefer a medication with a longer established track record, Semaglutide remains an excellent option and we offer both.
What to Know
Tirzepatide is well-tolerated by most patients. Side effects are most common during the first few weeks and diminish significantly as the body adjusts.
Typically mild and most pronounced in the first 1–2 weeks at a new dose. Usually resolves significantly within 4–6 weeks of each dose escalation.
Expected and desired patients eat less because the medication is working. This is not a side effect to be concerned about.
Diarrhea, constipation, or stomach discomfort may occur, especially early in the program. Usually transient and manageable.
Some patients experience mild fatigue in the first weeks. This typically resolves as the body adapts to reduced caloric intake and hormonal changes.
Starting at the lowest dose (2.5mg) and titrating gradually is the single most effective way to minimize GI side effects. We never rush this process.
Small, frequent, low-fat meals significantly reduce nausea. Our team provides specific dietary recommendations to help you through the adjustment period.
Adequate hydration helps manage GI symptoms. We provide a hydration protocol alongside your medication instructions.
Ready to experience the most powerful FDA-approved weight loss medication available? Our provider will review your eligibility, answer your questions, and build a personalized Tirzepatide program designed for your body and goals.
Tirzepatide is a once-weekly injectable medication that activates both GIP and GLP-1 hormone receptors simultaneously. This dual mechanism suppresses appetite at the neurological level, slows digestion to promote fullness, improves insulin sensitivity, and enhances fat cell metabolism producing weight loss significantly greater than any single-pathway medication. It is available under brand names Mounjaro® and Zepbound®.
The SURMOUNT-1 Phase 3 clinical trial showed an average body weight reduction of 20.9% (10mg) to 22.5% (15mg) over 72 weeks. 86% of patients achieved at least 5% weight loss, and 50% achieved at least 20% weight loss. These results are significantly higher than any previously approved weight loss medication. Individual results depend on adherence to your provider’s program, lifestyle modifications, and your individual metabolic response.
Yes. Restore Wellness Clinic in Waco, Texas offers physician supervised Tirzepatide treatment programs for eligible patients. We serve patients in Waco and throughout Central Texas. Book a consultation through our Tebra patient portal to get started.
Semaglutide activates only the GLP-1 hormone receptor. Tirzepatide activates both GLP-1 and GIP receptors making it a dual-agonist. Clinical trials show Tirzepatide produces approximately 7–8 percentage points greater average weight loss than Semaglutide. Tirzepatide is generally recommended for patients seeking maximum weight loss results. Semaglutide remains an excellent option, particularly for patients who prefer a medication with a longer safety track record. Your provider will recommend the most appropriate option for your individual situation.
Tirzepatide is administered as a once-weekly subcutaneous injection using a small auto-injector pen. It can be injected into the abdomen, thigh, or upper arm. Our team provides thorough injection training at your first appointment the technique is simple and most patients become comfortable within the first few doses.
The most common side effects are gastrointestinal nausea, mild stomach discomfort, and decreased appetite. These are most pronounced in the first 2–4 weeks at each new dose level and significantly diminish as your body adjusts. Our slow titration protocol (starting at 2.5mg) dramatically reduces side effect severity. Dietary modifications, adequate hydration, and our provider’s guidance help most patients manage the adjustment period comfortably.
All appointments at Restore Wellness Clinic are booked through our secure Tebra patient portal. Submit your information using the form on this page and our team will contact you within 24 hours to confirm your appointment and provide Tebra portal access for completing intake paperwork ahead of your visit.
While Tirzepatide dramatically reduces appetite, following your provider’s nutritional guidance is essential for achieving the best results and maintaining them long-term. Our team provides practical, sustainable dietary guidance not a rigid meal plan. Patients who integrate the lifestyle recommendations into their program achieve meaningfully better outcomes than those who rely on medication alone.
Visit our Restore Wellness Clinic for personalized care and wellness services. Our team is here to support your health journey in a comfortable and welcoming environment.
No obligation. We’ll reach out within 24 hours to confirm your appointment.
Tirzepatide represents the most significant breakthrough in obesity medicine in decades. With physician supervision, a personalized protocol, and the clinical evidence to back it up Restore Wellness Clinic is ready to help you achieve results that last.
